| Issue Date | Title | Author(s) |
| Jan-2022 | Efficacy and safety of a nanoparticle therapeutic vaccine in patients with chronic hepatitis B: A randomized clinical trial | Wei, Lai; Zhao, Tingting; Zhang, Ji; Mao, Qing; Gong, Guozhong; Sun, Yongtao; Chen, Yongping; Wang, Maorong; Tan, Deming; Gong, Zuojiong; Li, Baosen; Niu, Junqi; Li, Shuchen; Gong, Huanyu; Zou, Liyun; Zhou, Wei; Jia, Zhengcai; Tang, Yan; Fei, Lei; Hu, Yang; Shang, Xiaoyun; Han, Junfeng; Zhang, Bei; Wu, Yuzhang |
| Aug-2020 | Pradefovir in naive or experienced adult patients with chronic infection of hepatitis B virus: week24 results from 23 multicentre, double-blind, randomised, non-inferiority, phase2 trials | Gao, Yanhang; Kong, Fei; Li, Guangming; Mao, Qianguo; Zhang, Zong; Song, Xinwen; Shang, Jia; Yao, Lvfeng; Xia, Jinyu; Peng, Yanzhong; Liu, Weidong; Gong, Huanyu; Mu, Mao; Cui, Hesong; Han, Tao; Chen, Wen; Wu, Xiaolu; Yang, Yongfeng; Yan, Xuebing; Jin, Zhenjing; Wang, Peng; Zhu, Qingjing; Chen, Liang; Zhao, Caiyan; Zhang, Dengke; Jin, Weili; Wang, Daidi; Wen, Xiuhong; Wang, Tingchun; Tan, Bo; Ding, Yanhua; Niu, Junqi |
| Sep-2021 | Pradefovir Treatment in Patients With Chronic Hepatitis B: Week 24 Results From a Multicenter, Double-Blind, Randomized, Noninferiority, Phase 2 Trial | Gao, Yanhang; Kong, Fei; Song, Xinwen; Shang, Jia; Yao, Lvfeng; Xia, Jinyu; Peng, Yanzhong; Liu, Weidong; Gong, Huanyu; Mu, Mao; Cui, Hesong; Han, Tao; Chen, Wen; Wu, Xiaolu; Yang, Yongfeng; Yan, Xuebing; Jin, Zhenjing; Wang, Peng; Zhu, Qingjing; Chen, Liang; Zhao, Caiyan; Zhang, Dengke; Jin, Weili; Wang, Daidi; Wen, Xiuhong; Liu, Chunmei; Jia, Jidong; Mao, Qing; Ding, Yanhua; Jin, Xueyuan; Zhang, Zong; Mao, Qianguo; Li, Guangming; Niu, Junqi |
